Lirimilast
Lirimilast (BAY 19-8004; BAY 198004) is a potent and selective PDE4 inhibitor for the treatment of COPD.
Product Specifications
CAS Number
329306-27-6
Stability
≥ 2 years
Purity
>98% (HPLC)
Weight
443.251
Molecular Formula
C17H12Cl2N2O6S
Notes
Research use only, not for human use.
Receptor
PDE
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS6457292-01 0.1 mL
Mlf1 (Myeloid Leukemia Factor 1, Hematopoietic Lineage Switch 7, Myelodysplasia-Myeloid Leukemia Factor 1, Mlf1, Hls7) (MaxLight 650)
Ask
View Details 
MBS6457292-02 5x 0.1 mL
Mlf1 (Myeloid Leukemia Factor 1, Hematopoietic Lineage Switch 7, Myelodysplasia-Myeloid Leukemia Factor 1, Mlf1, Hls7) (MaxLight 650)
Ask
View Details 364721 200 µL
PP (Pancreatic Polypeptide, PPY, PNP, Pancreatic Polypeptide Y, Obinepitide, Pancreatic icosapeptide, Pancreatic prohormone)
Ask
View Details